Innogen Pharmaceuticals (HK.2591), a biopharmaceutical company dedicated to innovative drug discovery and industrialization in metabolic diseases, today announced that its Efsubaglutide alfa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results